During this innovative study published in PLOS One, researchers found that novel classes of compounds, such as metal-complexes, can be used as alternatives to or to supplement traditional antibiotics, which have become ineffective ...
Oct 23, 2017
0
2
Although scientists have known for centuries that many bacteria produce hydrogen sulfide (H2S) it was thought to be simply a toxic by-product of cellular activity. Now, researchers at NYU School of Medicine have discovered ...
Nov 17, 2011
0
0
A finding from University of Alberta researchers is shining new light on the role fibrinogen has in regulating a natural defence mechanism in the body. The discovery is hoped to contribute to improved diagnosis and treatments ...
Jun 11, 2019
0
7
(HealthDay)—Current infection prevention and antibiotic stewardship program practices continue to include a main focus on surveillance for multidrug-resistant organisms, according to a report published online July 17 in ...
Jul 19, 2019
0
3
New insight on how bacteria in the lungs protect against invading pathogens has been published today in the open-access eLife journal.
Dec 8, 2020
0
2
Australian researchers from The University of Queensland (UQ) have launched a global search to discover antibiotics capable of combating superbug bacteria that are resistant to current antibiotics.
Jun 18, 2015
0
10
Researchers at the University of California, Santa Cruz, have developed a new strategy for finding novel antibiotic compounds, using a diagnostic panel of bacterial strains for screening chemical extracts from natural sources.
Nov 26, 2012
0
0
A report by University of Queensland researchers has warned a global crisis of antibiotic resistance is inevitable, despite promising developments in new antibiotics.
Jul 25, 2023
0
1
Travellers carrying standby antibiotics take them more often than those traveling without such drugs. Antibiotics packed in the bags encourages misuse for mild and moderate diarrhoea, i.e., cases not requiring medication.
Jun 13, 2018
0
3
New research is paving the way for the development of innovative drugs that restore antibiotic susceptibility in antibiotic-resistant superbugs such as Klebsiella pneumoniae, a main cause of fatal lung and bloodstream infections ...
Mar 13, 2017
0
1
